Danish maker of bio-based ingredients Octarine Bio and US cell programming company Ginkgo Bioworks have partnered up to engineer a strain for producing violacein and its derivatives.
Startup Liberation Labs is one step closer to easing crippling capacity constraints holding back precision fermentation – one of the most promising technologies in the fast-growing alternative protein market – with an infusion of $30m in equipment financing to build out the “first” fit-for-purpose commercial-scale precision fermentation plant in the US.
The rapid increase in the number of chemical industries worldwide has emerged as a significant growth factor for the microbial fermentation technology.